Can Nesfatin-1 Predict Hypertension in Obese Children?

Creative Commons License

Gunes H., Baylan F. A., Gunes H., Temiz F.

JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, cilt.12, sa.1, ss.29-36, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Sayı: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.4274/jcrpe.galenos.2019.2019.0072
  • Dergi Adı: JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.29-36
  • Anahtar Kelimeler: Obesity, hypertension, Nesfatin-I, children, SYMPATHETIC-NERVE ACTIVITY, CONVERTING-ENZYME, AGED HYPERTENSION, SATIETY MOLECULE, BODY-COMPOSITION, BLOOD-PRESSURE, FOOD-INTAKE, OVERWEIGHT, COPPER, BRAIN
  • Erciyes Üniversitesi Adresli: Hayır

Özet

Objective: The prevalence of childhood obesity is increasing and leads to co-morbidities such as hypertension. However, it is still not clear why some obese individuals are hypertensive and others not. Nesfatin-1 is a recently discovered anorexigenic peptide which also has effects on blood pressure (BP). Our aim was to evaluate the relationship between obesity-related hypertension and Nesfatin-1.